LLS Research, along with the rest of Mission, announces special RFPs (requests for proposal) on a regular basis to accelerate blood cancer research areas with high unmet need as well as research that directly helps patients and their families.
For more information please contact us at [email protected]
HCL2025 guidelines
The HCLF and LLS joining forces to expanding research in Hairy Cell Leukemia to better characterize its biology, develop new therapies, and optimize outcomes for patients. Download the 2019 Request For Proposals or view our Statement on Future Research and Therapies for HCL.
LLS PedAL: Precision Medicine for Children with Leukemia
As part of The LLS Children’s Initiative, LLS is working with a team of renowned pediatric oncologists to lay the groundwork for a global precision medicine master clinical trial to match children with relapsed acute leukemia to a targeted therapy based on the specific abnormalities driving their cancer.
Study in Nature Medicine Shows Superior Outcomes for Patients in LLS's Paradigm-Shifting Beat AML Clinical Trial
Bringing Precision Medicine to AML patients: LLS’S Beat AML® Master Clinical Trial